Across TCGA pan-cancer cohorts, SNORA74C-1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of SNORA74C-1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where SNORA74C-1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA74C-1 is over-expressed in tumor.
COAD are the cancer types where SNORA74C-1 tumor–normal differential expression is most reproducible.